Andersons pediatric cardiology 1583

2006;53(1–2):103–112.
83.ClaeysM,VanderHoevenM,deDie-Smulders
C,etal.Early-infantiletypeofgalactosialidosis
asacauseofheartfailureandneonatalascites.J
InheritMetabDis.1999;22(5):666–667.
84.SewellAC,PontzBF,WeitzelD,HumburgC.
Clinicalheterogeneityininfantile
galactosialidosis.EurJPediatr.
1987;146(5):528–531.
85.SayB,HommesFA,MalikSA,CarpenterNJ.An
infantwithmultiplecongenitalabnormalities
andbiochemicalfindingssuggestingavariantof
galactosialidosis.JMedGenet.1992;29(6):423–
424.
86.BursiF,OsranekM,SewardJB,O'LearyPW.
Mitralandaorticvalvethickeningassociated
withgalactosialidosis:echocardiographic
featuresofalysosomalstoragedisease.
Echocardiography.2003;20(7):605–606.
87.HisaharaS,FujitaT,YoshizawaK,MizusawaH,
ShojiS.Twosiblingsofgalactosialidosiswith
markedprogressionofcardiacinvolvement
duringtenyears.RinshoShinkeigaku.
1996;36(4):562–565.
88.HinekA,PshezhetskyAV,vonItzsteinM,
StarcherB.Lysosomalsialidase(neuraminidase1)istargetedtothecellsurfaceinamultiprotein


complexthatfacilitateselasticfiberassembly.J
BiolChem.2006;281(6):3698–3710.
89.BontenEJ,WangD,ToyJN,etal.Targeting

marcophageswithbaculovirus-produced
lysosomalenzymes:implicationsforenzyme
replacementtherapyoftheglycoproteinstorage
disordergalactosialidosis.FASEBJ.
2004;18(9):971–973.
90.Deletedinreview.
91.AnnunziataI,d'AzzoA.Galactosialidosis:
historicaspectsandoverviewofinvestigatedand
emergingtreatmentoptions.ExpertOpin
OrphanDrugs.2017;5(2):131–141.
92.AronsonNNJr.Aspartylglycosaminuria:
biochemistryandmolecyularbiology.Biochim
BiophysActa.1999;1455(2–3):139–154.
93.KeloE,DunderU,MononenI.Massive
accumulationofMan2GlcNAc2-asnin
nonneuronaltissuesofglycosylasparaginasedeficientmiceanditsremovalbyenzyme
replacementtherapy.Glycobiology.
2005;15(1):79–85.
94.ArvioM,MononenI.Aspartylglycosaminuria:a
review.OrphanetJRareDis.2016;11:162.
95.EllederM,ChlumskaA,HyanekJ,etal.
Subclinicalcourseofcholesterylesterstorage
diseaseinanadultwithhypercholesterolemia,


acceleratedatherosclerosis,andlivercancer.J
Hepatol.2000;32(3):528–534.
96.KrivitW,PetersC,DusenberyK,etal.Wolman
diseasesuccessfullytreatedbybonemarrow
transplantation.BoneMarrowTransplant.

2000;26(5):567–570.
97.SteinJ,ZionGartyB,DrorY,etal.Successful
treatmentofwolmandiseasebyunrelated
umbilicalcordbloodtransplantation.EurJ
Pediatr.2006.
98.AguisandaF,ThorneN,ZhengW.Targeting
wolmandiseaseandcholesterylesterstorage
disease:diseasepathogenesisandtherapeutic
development.CurrChemGenomTranslMed.
2017;11:1–18.
99.SchuchmanEH,DesnickRJ.TypesaandB
Niemann-pickdisease.MolGenetMetab.
2017;120(1–2):27–33.
100.EvansWR,HendrikszCJ.Niemann-picktypeC
disease-thetipoftheiceberg?Areviewof
neuropsychiatricpresentation,diagnosisand
treatment.BJPsychBull.2017;41(2):109–114.
101.WestwoodM.Endocardialfibroelastosisand
Niemann–Pickdisease.BrHeartJ.
1977;39:1394–1396.
102.McGovernMM,Pohl-WorgallT,Deckelbaum
RJ,etal.Lipidabnormalitiesinchildrenwith